A New Year, but the Same Old Stock Market
The new year was to have brought a new beginning for China's stock market. Instead, investors who were set to welcome the return of IPO action after a suspension of 14 months were disappointed by news on January 10 that Jiangsu Aosaikang Pharmaceutical Co. Ltd. was putting its anticipated initial public offering on hold.
The abrupt postponement has sparked questions about the regulator's reform agenda. Clearly, at a time when it is trying to clarify its own role vis-à-vis the market, the regulator has yet to master the art of timing. Xiao Gang, chairman of the China Securities Regulatory Commission, said at a work conference this month that reform will see a complete overhaul of the regulator's scope of oversight of the capital market. Its recent actions must be seen in light of this pledge.
- Hidden Anguish
- In Friday's Papers: IBM Workers Strike over Lenovo Deal; Ordos Will Stop Building Homes, Mayor Says
- A French Revolution, Please!
- Lianghui Quotes：March 7
- Egypt's Road to Rejuvenation Is Opening, Veteran Diplomat Says
- Scaffold Collapse
- The Siege of Tsingtao
- The Celestials
- Jilted U.S. Investors and Debtors on the Run
- Lianghui Quotes: March 6
- Sign up to receive our free daily newsletter
- Eyes on the Prize
- Electric Car Charging Stations Powering Down
- Zhou Family Was Influential in Jiangsu City before Corruption Inquiry
- The Logic of the Left in China
- Yuan Won't Overtake Dollar until Changes Are Made, Economist Says
- Caixin Explains: The 'Lianghui' Meetings
- From Tycoon to Target
- Gary Locke Expresses Optimism for Future of Sino-U.S. Ties
- Closer Look: So Who Stops a Run on Yu E Bao Accounts?
- China to Grow at 7.5 Pct and Focus on Reforms, Premier Says